» Articles » PMID: 19549035

Transcranial Measurement of Cerebral Microembolic Signals During Endocardial Pulmonary Vein Isolation: Comparison of Three Different Ablation Techniques

Overview
Date 2009 Jun 25
PMID 19549035
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Isolation of the pulmonary veins (PVI) using high ablation energy is an effective treatment for atrial fibrillation (AF) with a success rate of 50-95%; however, postoperative neurological complications still occur in 0.5-10%. In this study the incidence of cerebral microembolic signals (MES) as a risk factor for neurological complications is examined during 3 percutaneous endocardial ablation procedure strategies: segmental PVI using a conventional radiofrequency (RF) ablation catheter, segmental PVI using an irrigated RF tip catheter, and circumferential PVI with a cryoballoon catheter (CB).

Methods And Results: Thirty patients underwent percutaneous endocardial PVI. Ostial isolation was performed in 10 patients with a conventional 4-mm RF catheter (CRF) and in 10 patients with a 4-mm irrigated RF catheter (IRF). A circumferential PVI was performed in 10 patients with a CB. Transcranial Doppler (TCD) monitoring was used to detect MES in the middle cerebral arteries. The total number of cerebral MES differs significantly among the 3 PVI groups; 3,908 cerebral MES were measured with use of the CRF catheter, 1,404 cerebral MES with use of the IRF catheter, and 935 cerebral MES with use of the CB catheter.

Conclusion: This study demonstrates a significant difference in cerebral MES during PVI with 3 different ablation procedures. The use of an irrigated RF and a cryoballoon produces significantly fewer cerebral MES than the use of conventional RF for a PVI procedure, suggesting a higher risk for neurologic complications using conventional RF energy during a percutaneous PVI procedure.

Citing Articles

Neuroprotection Devices in Cardiac Catheterization Laboratories: Does It Sufficiently Protect Our Patients?.

Tan C, Higgins M, Thanabalasingam V, Sella Kapu C, Zhang Z Medicina (Kaunas). 2025; 61(2).

PMID: 40005422 PMC: 11857601. DOI: 10.3390/medicina61020305.


Microembolizations in the arterial cerebral circulation during atrial fibrillation ablation: cryoballoon technique advantages and neurocognitive safety-results of a prospective observational study.

Erkapic D, Roussopoulos K, Aleksic M, Weipert K, Sozener K, Kostev K Europace. 2024; 26(9).

PMID: 39180328 PMC: 11411211. DOI: 10.1093/europace/euae222.


Balloon surface temperature-controlled ablation using a second-generation radiofrequency HotBalloon: an in vivo feasibility study.

Shinoda Y, Yamasaki H, Murakoshi N, Kohno T, Yamane T, Aonuma K Europace. 2023; 25(12).

PMID: 37950630 PMC: 10751809. DOI: 10.1093/europace/euad340.


Fighting Cardiac Thromboembolism during Transcatheter Procedures: An Update on the Use of Cerebral Protection Devices in Cath Labs and EP Labs.

Preda A, Montalto C, Galasso M, Munafo A, Garofani I, Baroni M Life (Basel). 2023; 13(9).

PMID: 37763223 PMC: 10532856. DOI: 10.3390/life13091819.


Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review.

Calvert P, Kollias G, Purerfellner H, Narasimhan C, Osorio J, Lip G Europace. 2023; 25(6).

PMID: 37306314 PMC: 10259069. DOI: 10.1093/europace/euad151.